Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v21-FR Version v18-FR
Language French French
Date Updated 2019-07-05 2019-04-18
Drug Identification Number 00616192 00616192
Brand name VEPESID VEPESID
Common or Proper name Etoposide Etoposide
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients ETOPOSIDE ETOPOSIDE
Strength(s) 50MG 50MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 1 BTL x 20 1 BTL x 20
ATC code L01CB L01CB
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-07-01 2019-07-01
Actual start date
Estimated end date 2019-07-01 2019-07-01
Actual end date 2019-07-01
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Stock is being allocated. Generics on back order for Etoposide IV has increased demand for Vepesid capsules. Stock is being allocated. Generics on back order for Etoposide IV has increased demand for Vepesid capsules.
Health Canada comments